HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Oncology Today with Dr Neil Love · Jun 29, 2026 · 1h 39m

Featuring perspectives from Dr Erika Hamilton, Dr Jane Lowe Meisel, Dr Joyce O’Shaughnessy and Dr Seth Wander, including the following topics:

Introduction (0:00)

Current and Future Management of HR-Positive, HER2-Negative Localized Breast Cancer — Dr Meisel(2:40)

Optimizing First-Line Therapy for Patients with HR-Positive Metastatic Breast Cancer (mBC) — Dr Hamilton (36:57)

Current and Future Role of Oral Selective Estrogen Receptor Degraders for Progressive HR-Positive mBC — Dr Wander (58:18)

Clinical Utility of Agents Targeting the PI3K/AKT/mTOR Pathway for Patients with Progressive…